Particle.news

Download on the App Store

White House Advances Tylenol Pregnancy Warnings as FDA Issues Nuanced Guidance

Researchers and medical societies say a causal link to autism is unproven, urging pregnant patients to seek individualized advice.

Overview

  • President Trump urged pregnant women not to take Tylenol and announced plans for acetaminophen warning labels, promotion of leucovorin, and new autism research funding reported at $50 million.
  • An FDA letter to clinicians said a causal relationship between prenatal acetaminophen and autism has not been established, advising caution for routine low‑grade fevers while noting it remains the safest over‑the‑counter option in pregnancy.
  • Authors of a review cited by the administration said their paper is being misinterpreted and recommended judicious, short‑term use under medical supervision rather than avoiding the medication outright.
  • Obstetric and pediatric experts warned that untreated fever or severe pain in pregnancy carries known risks for mother and fetus, and they continue to recommend acetaminophen when medically indicated.
  • Autistic people and families expressed sharply mixed reactions, and reporting highlighted ties between administration allies and supplement and anti‑vaccine groups that have promoted alternatives to acetaminophen.